Cargando…

Ethyl 7-(4-bromo­phen­yl)-5-trifluoro­methyl-4,7-dihydro­tetra­zolo[1,5-a]pyrimidine-6-carboxyl­ate

In the title compound, C(14)H(11)BrF(3)N(5)O(2), the pyrimidine ring adopts a flattened envelope conformation with sp (3)-hybridized carbon as the flap [deviation = 0.177 (3) Å]. The dihedral angle between tetra­zole and bromo­phenyl rings is 84.3 (1)°. In the crystal, mol­ecules are linked into cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Shi-De, Feng, Xiao-Dong, Yang, Wei-Hua, Yao, Chang-Sheng
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008060/
https://www.ncbi.nlm.nih.gov/pubmed/21588746
http://dx.doi.org/10.1107/S1600536810033842
Descripción
Sumario:In the title compound, C(14)H(11)BrF(3)N(5)O(2), the pyrimidine ring adopts a flattened envelope conformation with sp (3)-hybridized carbon as the flap [deviation = 0.177 (3) Å]. The dihedral angle between tetra­zole and bromo­phenyl rings is 84.3 (1)°. In the crystal, mol­ecules are linked into centrosymmetric dimers by pairs of N—H⋯N hydrogen bonds.